CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Open-market sale GRAMMER ELIZABETH A sold 5,992 shares at $4.08 ($24,456)
- 4 Open-market sale Chief Commercial Officer sold 2,507 shares at $4.08 ($10,232)
- 4 Open-market buy Director bought 100,000 shares at $3.29 ($329,120)
- 4 Grant or award Director acquired 42,056 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 381,377 shares at $4.22 ($1,610,936)
- 4 Planned sale President & CEO sold 41,666 shares at $4.25 ($177,168)
- 4 Planned sale President & CEO sold 41,666 shares at $4.59 ($191,151)
- 4 Planned sale President & CEO sold 41,668 shares at $5.36 ($223,199)
- 4 Grant or award Chief Medical Officer acquired 105,200 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 136,680 shares (grant or award)
- 4 Grant or award President & CEO acquired 570,217 shares (grant or award)
- 4 Grant or award Kelliher Mike acquired 136,680 shares (grant or award)
- 4 Grant or award GRAMMER ELIZABETH A acquired 136,680 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 136,680 shares (grant or award)
- 4 Open-market buy Director bought 77,729 shares at $5.00 ($388,738)
- 4 Open-market sale Chief Medical Officer sold 4,941 shares at $5.62 ($27,783)
- 4 Open-market sale Chief Financial Officer sold 5,171 shares at $5.62 ($29,077)
- 4 Open-market sale President & CEO sold 22,964 shares at $5.62 ($129,124)
- 4 Open-market sale GRAMMER ELIZABETH A sold 4,291 shares at $5.62 ($24,128)
Page 5 of 35 · 690 filings